County to join opioid settlement that includes Suboxone and Sublocade allocations for detention centers

Staff member (S7) described a statewide participation agreement negotiated by the Maryland attorney general that allocates $1.5 million in cash and $2 million in medication product across the state. "Product, specifically Suboxone and Sublocade," S7 said, and staff explained the product will be made available to participating detention centers on a first-come, first-served basis for opioid-treatment needs.

Under the state's allocation formula, the county's share would be $5,369.34 in direct funds and $9,664.82 in targeted abatement grants. S7 said the medication allocation's wholesale value is estimated to last about four years across participating correctional facilities, and the county must sign the participation agreement by Oct. 7 to receive the benefits.